Abiopharma

🔍 BUSQUET ANNE (Director)

Company: CareCloud, Inc. (CCLD)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 6,250 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 301,388.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 25,000 shares of Restricted Stock Unit (Derivative)
  Date: 2026-07-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 51,250.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Sold 6,250 shares of Restricted Stock Unit (Derivative)
  Date: 2026-07-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 45,000.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

Footnotes:

• F1: The restricted stock unit grant was approved on July 29, 2026 and vests in four equal installments on January 29, 2027, July 29, 2027, January 29, 2028 and July 29, 2028.
• F2: Represents the conversion upon vesting of restricted stock units into common stock on July 31, 2026. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person.